The Journal of Immunology, Vol 155, Issue 6 3245-3252, Copyright © 1995 by American Association of Immunologists

ARTICLES

Sequences of V kappa L subgroup light chains in Fanconi's syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome

A Rocca, AA Khamlichi, G Touchard, B Mougenot, P Ronco, L Denoroy, S Deret, JL Preud'homme, P Aucouturier and M Cogne
CNRS Unit 1172, University Hospital and Science Faculty, Poitiers, France.

Certain monoclonal Ig light chains (LC) are responsible for marked disturbances of proximal tubule cell functions (Fanconi's syndrome, FS). In patients with FS, intracellular crystal-like inclusions containing LC determinants are commonly found in plasma cells, macrophages, and renal tubular cells. In an attempt at understanding the pathogenesis of myeloma-associated FS, we recently determined the first complete primary sequence of a kappa-LC (CHEB) responsible for the disease. We now report on the primary structure of three other kappa-LC of the V kappa l variability subgroup associated with FS (TRE, TRO, and DEL). After PCR amplification, cDNA encoding these LC were sequenced. CHEB, TRE, and TRO LC genes were found to be highly homologous to the same germline gene O2/O12. These patients had numerous intracellular crystals, whereas the fourth patient, DEL, had no detectable crystals. The LC from the latter patient was homologous to another germline gene, O8/O18. Comparison of these LC sequences to previously reported LC of the V kappa l subgroup allowed identification of a number of unusual amino acid substitutions in the V region that had rarely or never been previously described at the corresponding positions. Some of these unusual substitutions affect highly conserved amino acids located either in an external loop (residue 30) or in inner (residues 48 and 55) and outer (positions 63 and 72) beta-sheets that may be important for the structure and binding properties of the kappa- chains. These and several other substitutions, some of them shared with amyloidogenic kappa-LC, could induce conformational alterations and represent a determinant pathogenic factor.

This article has been cited by other articles:

				G. Merlini and M. J. Stone Dangerous small B-cell clones Blood, October 15, 2006; 108(8): 2520 - 2530. [Abstract] [Full Text] [PDF]

				C. Sirac, F. Bridoux, C. Carrion, O. Devuyst, B. Fernandez, J.-M. Goujon, C. E. Hamel, J.-C. Aldigier, G. Touchard, and M. Cogne Role of the monoclonal {kappa} chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome Blood, July 15, 2006; 108(2): 536 - 543. [Abstract] [Full Text] [PDF]

				C. X. Ma, M. Q. Lacy, J. F. Rompala, A. Dispenzieri, S. V. Rajkumar, P. R. Greipp, R. Fonseca, R. A. Kyle, and M. A. Gertz Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma Blood, July 1, 2004; 104(1): 40 - 42. [Abstract] [Full Text] [PDF]

				A. Lebeau, E. Zeindl-Eberhart, E.-C. Muller, J. Muller-Hocker, P. R. Jungblut, B. Emmerich, and U. Lohrs Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature Blood, August 13, 2002; 100(5): 1817 - 1827. [Abstract] [Full Text] [PDF]

				J.-U. Rengers, G. Touchard, C. Decourt, S. Deret, H. Michel, and M. Cogne Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia Blood, June 1, 2000; 95(11): 3467 - 3472. [Abstract] [Full Text] [PDF]

				C. Decourt, A. Rocca, F. Bridoux, F. Vrtovsnik, J.L. Preud'homme, M. Cogne, and G. Touchard Mutational Analysis in Murine Models for Myeloma-Associated Fanconi's Syndrome or Cast Myeloma Nephropathy Blood, November 15, 1999; 94(10): 3559 - 3566. [Abstract] [Full Text] [PDF]

				S. Deret, L. Denoroy, M. Lamarine, R. Vidal, B. Mougenot, B. Frangione, F. J. Stevens, P. M. Ronco, and P. Aucouturier Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals Protein Eng. Des. Sel., April 1, 1999; 12(4): 363 - 369. [Abstract] [Full Text] [PDF]